Combined hepatocellular-cholangiocarcinoma（CHC） is a mixed tumor containing elements of both hepatocellular carcinoma（HCC） and cholangiocarcinoma（CC）. Its remarkable histological heterogeneity has been linked to...Combined hepatocellular-cholangiocarcinoma（CHC） is a mixed tumor containing elements of both hepatocellular carcinoma（HCC） and cholangiocarcinoma（CC）. Its remarkable histological heterogeneity has been linked to putative hepatic progenitor cell（HPC） origin. However, detailed histological or phenotypic description is rarely documented. In the present study, we reassessed 68 cases previously diagnosed as hepatitis B-related CHCs by immunohistochemistry and double-fluorescence immunostaining, focusing on HPC associated phenotypic observation of intermediate area of the tumor. It was found that tumor cells showed remarkable heterogeneity in intermediate area. Tumor cells with intermediate morphology between hepatocytes and cholangiocytes were oval-shaped and small with scant cytoplasm and hyperchromatic nuclei, arranging in solid nests mostly. By Keratin 7（K7） staining, it appeared that the nests of tumor cells represented a maturation process from the undifferentiated small cells to mature hepatocytes through the ＂transitional＂ cells. Then, these small cells were further confirmed with intermediate phenotype as HPC by exploring immature hepatocellular marker and HPC/biliary markers co-localization. In conclusion, the HPC associated trait in CHC can be interpreted by HPC origin or gain of ＂stemness＂ by dedifferentiation. It is still too soon to give a final word that it is innate or acquired signature of HPC associated trait in CHC.展开更多
基金supported by grants from National Natural Science Foundation of China(No.81302130)Military Medical Scientific Youth Cultivation Project(No.13QNP054)
文摘Combined hepatocellular-cholangiocarcinoma（CHC） is a mixed tumor containing elements of both hepatocellular carcinoma（HCC） and cholangiocarcinoma（CC）. Its remarkable histological heterogeneity has been linked to putative hepatic progenitor cell（HPC） origin. However, detailed histological or phenotypic description is rarely documented. In the present study, we reassessed 68 cases previously diagnosed as hepatitis B-related CHCs by immunohistochemistry and double-fluorescence immunostaining, focusing on HPC associated phenotypic observation of intermediate area of the tumor. It was found that tumor cells showed remarkable heterogeneity in intermediate area. Tumor cells with intermediate morphology between hepatocytes and cholangiocytes were oval-shaped and small with scant cytoplasm and hyperchromatic nuclei, arranging in solid nests mostly. By Keratin 7（K7） staining, it appeared that the nests of tumor cells represented a maturation process from the undifferentiated small cells to mature hepatocytes through the ＂transitional＂ cells. Then, these small cells were further confirmed with intermediate phenotype as HPC by exploring immature hepatocellular marker and HPC/biliary markers co-localization. In conclusion, the HPC associated trait in CHC can be interpreted by HPC origin or gain of ＂stemness＂ by dedifferentiation. It is still too soon to give a final word that it is innate or acquired signature of HPC associated trait in CHC.
